Investment
Features
FeesSafety
Academy
More
Pluang+

OpenAI plans $750B compute spend by 2030 but faces capacity and funding challenges impacting Oracle.

Market News
09 Sep 2026
24/7 Wall Street
View Source
Neutral
OpenAI plans $750B compute spend by 2030 but faces capacity and funding challenges impacting Oracle.

OpenAI has increased its planned spending on compute infrastructure to $750 billion by 2030, a 25% rise from earlier estimates, yet it still reports a significant capacity shortfall. This massive demand highlights the strain on suppliers like Oracle, which holds a $638 billion backlog but faces cash flow challenges with negative free cash flow and rising liabilities. Oracle plans to raise $40 billion in 2027 to fund this growth, while other players like CoreWeave and NVIDIA also report supply constraints. The situation underscores a critical supply-demand imbalance in AI infrastructure, making Oracle's ability to convert backlog into cash flow a key investor focus in upcoming earnings reports.

More News (ORCL)

Fed meeting looms over Amazon and Oracle's costly AI cloud expansions amid negative cash flow.

Fed meeting looms over Amazon and Oracle's costly AI cloud expansions amid negative cash flow.

Amazon and Oracle reported record cloud backlogs but are facing negative free cash flow due to massive investments in AI data centers. Oracle plans $70 billion in capital expenditures for FY2027, funded by $40 billion in new debt and equity, while Am...

Market News
Neutral
5 hours ago
Oracle stock seen with 35% upside as AI growth and $638B backlog fuel bullish outlook.

Oracle stock seen with 35% upside as AI growth and $638B backlog fuel bullish outlook.

Oracle's stock has rebounded strongly, with a 24/7 Wall St. price target of $219.26, implying a 34.91% upside from its recent close of $162.52. The company boasts a massive $638 billion backlog and 93% growth in cloud infrastructure revenue, driven b...

Analyst Insights
Bullish
5 hours ago
NYSE pre-market update highlights Covenant's defense launch and Moonwalk Bio's RNAi progress.

NYSE pre-market update highlights Covenant's defense launch and Moonwalk Bio's RNAi progress.

The NYSE pre-market update on September 9, 2026, featured key developments including defense company Covenant emerging from stealth with a new factory and heavy-payload weapon system, backed by over $250 million in funding. Moonwalk Bio announced pro...

Market News
Bullish
8 hours ago
Oracle upgrades to speculative buy amid AI-driven growth and data center expansion challenges.

Oracle upgrades to speculative buy amid AI-driven growth and data center expansion challenges.

Oracle's connection to OpenAI, with about 47% of its remaining performance obligation linked to the AI firm, has shifted investor sentiment positively. Despite concerns over a $70 billion capital expenditure plan for fiscal 2027 and local resistance ...

Analyst Insights
Bullish
8 hours ago
Adobe offers steady growth and stability, while Oracle's earnings reveal high-risk AI infrastructure bets.

Adobe offers steady growth and stability, while Oracle's earnings reveal high-risk AI infrastructure bets.

Adobe and Oracle are set to report earnings, highlighting contrasting investment profiles. Adobe shows steady, profitable growth with a strong subscription model and solid cash flow, making it a safer choice for retirement investors despite lacking a...

Company Fundamentals
Neutral
8 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App